Bayer - research.bayer.com - Bayer Corporate News

Latest News:

Nexavar® (sorafenib) Granted Priority Review for Differentiated Thyroid Cancer in the U.S. (for specialized target groups only) 27 Aug 2013 | 11:30 am

Currently no approved therapies specifically for differentiated thyroid cancer refractory to radioactive iodine

Bayer: strong growth in Life Sciences 31 Jul 2013 | 10:30 am

HealthCare and CropScience post dynamic growth, MaterialScience weak / New pharmaceutical products well above expectations / Group sales rise 1.9 percent (Fx & portfolio adj. 4.6 percent) to EUR 10,36...

Bayer holds official 150th anniversary celebration 16 Jul 2013 | 08:40 pm

More than 1,000 guests in Cologne / German Chancellor Merkel: Bayer is an outstanding advertisement for Germany / North Rhine-Westphalian State Premier Kraft: We need the chemical industry for the sak...

Sorafenib (Nexavar®) Submitted to the EMA and FDA for the Treatment of Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thy... 1 Jul 2013 | 11:30 am

Currently no approved therapies specifically for differentiated thyroid cancer refractory to radioactive iodine / Regulatory submissions based on data from Phase III DECISION trial, in which sorafenib...

Related Keywords:

bayer, bayer healthcare, bayer ag, bayer schering pharma, bayer schering, bayer corporation, bayer logo, bayer aspirin, bayer pharma

Recently parsed news:

Recent searches: